Kathryn Fort, MD, is a Child and Adolescent Psychiatry Resident at the NYU Child Study Center. Her clinical interests include treatment of adolescent mood and anxiety disorders, borderline personality disorder, and childhood trauma through use of psychopharmacology and multiple therapy modalities including CBT, DBT, psychodynamic therapy, and family therapy.
Dr. Fort received her BA in psychology at College of the Holy Cross and her MD from State University of New York Upstate Medical University. She completed her general psychiatry residency training at University of Maryland/Sheppard Pratt.
During her adult psychiatry residency, Dr. Fort participated in the Adult Psychoanalytic Fellowship Program at the Baltimore Washington Institute for Psychoanalysis. She coauthored a systematic review and meta-analysis on the efficacy of guanfacine for treatment of ADHD (pending submission for publication) and presented a poster on this topic at the University of Maryland Department of Psychiatry Research Day. Dr. Fort has completed the Buprenorphine in the Treatment of Opioid Dependence Course with license to prescribe.
Dr. Fort is a member of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry.